209 related articles for article (PubMed ID: 35008681)
21. Ochratoxin A transport by the human breast cancer resistance protein (BCRP), multidrug resistance protein 2 (MRP2), and organic anion-transporting polypeptides 1A2, 1B1 and 2B1.
Qi X; Wagenaar E; Xu W; Huang K; Schinkel AH
Toxicol Appl Pharmacol; 2017 Aug; 329():18-25. PubMed ID: 28532671
[TBL] [Abstract][Full Text] [Related]
22. Decreased expression of organic cation transporters, Oct1 and Oct2, in brain microvessels and its implication to MPTP-induced dopaminergic toxicity in aged mice.
Wu KC; Lu YH; Peng YH; Tsai TF; Kao YH; Yang HT; Lin CJ
J Cereb Blood Flow Metab; 2015 Jan; 35(1):37-47. PubMed ID: 25248837
[TBL] [Abstract][Full Text] [Related]
23. Interaction of six protoberberine alkaloids with human organic cation transporters 1, 2 and 3.
Li L; Sun S; Weng Y; Song F; Zhou S; Bai M; Zhou H; Zeng S; Jiang H
Xenobiotica; 2016; 46(2):175-83. PubMed ID: 26134304
[TBL] [Abstract][Full Text] [Related]
24. Lack of Interactions Between an Antisense Oligonucleotide with 2'-O-(2-Methoxyethyl) Modifications and Major Drug Transporters.
Yu RZ; Warren MS; Watanabe T; Nichols B; Jahic M; Huang J; Burkey J; Geary RS; Henry SP; Wang Y
Nucleic Acid Ther; 2016 Apr; 26(2):111-7. PubMed ID: 26959999
[TBL] [Abstract][Full Text] [Related]
25. Involvement of organic cation transporter 1 and CYP3A4 in retrorsine-induced toxicity.
Tu M; Li L; Lei H; Ma Z; Chen Z; Sun S; Xu S; Zhou H; Zeng S; Jiang H
Toxicology; 2014 Aug; 322():34-42. PubMed ID: 24799337
[TBL] [Abstract][Full Text] [Related]
26. Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathy.
Grube M; Ameling S; Noutsias M; Köck K; Triebel I; Bonitz K; Meissner K; Jedlitschky G; Herda LR; Reinthaler M; Rohde M; Hoffmann W; Kühl U; Schultheiss HP; Völker U; Felix SB; Klingel K; Kandolf R; Kroemer HK
Am J Pathol; 2011 Jun; 178(6):2547-59. PubMed ID: 21641380
[TBL] [Abstract][Full Text] [Related]
27. Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake.
Choi MK; Song IS
Biopharm Drug Dispos; 2012 Apr; 33(3):170-8. PubMed ID: 22415520
[TBL] [Abstract][Full Text] [Related]
28. Raltegravir has a low propensity to cause clinical drug interactions through inhibition of major drug transporters: an in vitro evaluation.
Rizk ML; Houle R; Chan GH; Hafey M; Rhee EG; Chu X
Antimicrob Agents Chemother; 2014; 58(3):1294-301. PubMed ID: 24295974
[TBL] [Abstract][Full Text] [Related]
29. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
Jong NN; Nakanishi T; Liu JJ; Tamai I; McKeage MJ
J Pharmacol Exp Ther; 2011 Aug; 338(2):537-47. PubMed ID: 21606177
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of berberine.
Sun S; Wang K; Lei H; Li L; Tu M; Zeng S; Zhou H; Jiang H
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():1-6. PubMed ID: 24246570
[TBL] [Abstract][Full Text] [Related]
31. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions.
Visentin M; van Rosmalen BV; Hiller C; Bieze M; Hofstetter L; Verheij J; Kullak-Ublick GA; Koepsell H; Phoa SS; Tamai I; Bennink RJ; van Gulik TM; Stieger B
Drug Metab Dispos; 2017 Feb; 45(2):166-173. PubMed ID: 27903597
[TBL] [Abstract][Full Text] [Related]
32. Stereoselective cell uptake of adrenergic agonists and antagonists by organic cation transporters.
Jensen O; Rafehi M; Tzvetkov MV; Brockmöller J
Biochem Pharmacol; 2020 Jan; 171():113731. PubMed ID: 31783011
[TBL] [Abstract][Full Text] [Related]
33. Efavirenz reduces renal excretion of lamivudine in rats by inhibiting organic cation transporters (OCT, Oct) and multidrug and toxin extrusion proteins (MATE, Mate).
Ceckova M; Reznicek J; Deutsch B; Fromm MF; Staud F
PLoS One; 2018; 13(8):e0202706. PubMed ID: 30114293
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of organic cation transporter (OCT) activities by carcinogenic heterocyclic aromatic amines.
Sayyed K; Camillerapp C; Le Vée M; Bruyère A; Nies AT; Abdel-Razzak Z; Fardel O
Toxicol In Vitro; 2019 Feb; 54():10-22. PubMed ID: 30189235
[TBL] [Abstract][Full Text] [Related]
35. In vitro interaction of clopidogrel and its hydrolysate with OCT1, OCT2 and OAT1.
Li L; Song F; Tu M; Wang K; Zhao L; Wu X; Zhou H; Xia Z; Jiang H
Int J Pharm; 2014 Apr; 465(1-2):5-10. PubMed ID: 24530383
[TBL] [Abstract][Full Text] [Related]
36. Calcitriol and Calcipotriol Modulate Transport Activity of ABC Transporters and Exhibit Selective Cytotoxicity in MRP1-overexpressing Cells.
Tan KW; Sampson A; Osa-Andrews B; Iram SH
Drug Metab Dispos; 2018 Dec; 46(12):1856-1866. PubMed ID: 30232176
[TBL] [Abstract][Full Text] [Related]
37. Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).
Nies AT; Hofmann U; Resch C; Schaeffeler E; Rius M; Schwab M
PLoS One; 2011; 6(7):e22163. PubMed ID: 21779389
[TBL] [Abstract][Full Text] [Related]
38. Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.
Nies AT; Koepsell H; Winter S; Burk O; Klein K; Kerb R; Zanger UM; Keppler D; Schwab M; Schaeffeler E
Hepatology; 2009 Oct; 50(4):1227-40. PubMed ID: 19591196
[TBL] [Abstract][Full Text] [Related]
39. Interactions with selected drug renal transporters and transporter-mediated cytotoxicity in antiviral agents from the group of acyclic nucleoside phosphonates.
Mandíková J; Volková M; Pávek P; Česnek M; Janeba Z; Kubíček V; Trejtnar F
Toxicology; 2013 Sep; 311(3):135-46. PubMed ID: 23856525
[TBL] [Abstract][Full Text] [Related]
40. An in vitro study on interaction of anisodine and monocrotaline with organic cation transporters of the SLC22 and SLC47 families.
Chen JY; Brockmöller J; Tzvetkov MV; Wang LJ; Chen XJ
Chin J Nat Med; 2019 Jul; 17(7):490-497. PubMed ID: 31514980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
